Investor Presentations

Tau Capital PLC

28th May 2012

TAU CAPITAL PLC

("Tau" or "the Company")

Investor Presentations

The Company will be making a number of presentations to investors this week and the presentation that they will be using will be available shortly and posted on the Company's website at www.taucapitalplc.com.

Two statements made in the presentation in relation to the Company's private equity investments are potentially price sensitive and the Company has set these out below.

STOPHARM LLP ("Stopharm")

January - April 2012 revenues* increased by 37% compared to budgeted revenues, reaching $98.2M and Gross profit +43.7% above budget, reaching $13.8M. EBITDA* for the four months ended April 2012 reached $7.8M, 154% higher than budgeted with EBITDA Margin* of 8% vs. 4.3% budgeted.

LUCENT PETROLEUM LLP ("Lucent")

Total consideration paid $15M, current carrying value $11.25M, written down by 25% based on extension of timeline to determine commerciality of Lebyazhye well. Lucent raised additional funds in Q4 2011 of $30M through third party financing.

*All financials are provisional and are derived from management accounts and subject to review and restatement.

Additionally, the largest listed equities positions as of 18th May 2012 were as follows, expressed as percentage of total NAV:

Zhaikmunai 7.2%

Dragon Oil 6.2%

Uranium One 5.4%

Polymetal 4.7%

Sberbank 3.8%

ENRC 3.1%

Mongolian Mining 2.7%

Centerra Gold 2.5%

Ivanhoe Mines 2.3%

KazMunaiGas EP 2.2%

--ENDS--

Further information, please contact:

Compass Asset Management

Brian O'Callaghan

 Tel: +7 727 356 0356

Richard Horlick

 Tel : +44 (0) 7770 496207

IOMA Fund and Investment Management Ltd

Philip Scales

 Tel: +44 (0) 1624 681250

Numis Securities Ltd

Nominated Adviser: Nick Westlake / Hugh Jonathan

Corporate Broking: Alex Ham

 Tel: +44 (0) 20 7260 1000